RWA
Redhawk Wealth Advisors’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.15M | Buy |
+47,497
| New | +$1.15M | 0.14% | 134 |
|
|
2025
Q1 | – | Sell |
-7,971
| Closed | -$211K | – | 323 |
|
|
2024
Q4 | $211K | Sell |
7,971
-895
| -10% | -$23.7K | 0.03% | 279 |
|
|
2024
Q3 | $257K | Sell |
8,866
-1,430
| -14% | -$41.4K | 0.04% | 259 |
|
|
2024
Q2 | $288K | Sell |
10,296
-197
| -2% | -$5.51K | 0.04% | 231 |
|
|
2024
Q1 | $291K | Sell |
10,493
-416
| -4% | -$11.5K | 0.05% | 254 |
|
|
2023
Q4 | $314K | Buy |
10,909
+538
| +5% | +$15.5K | 0.06% | 217 |
|
|
2023
Q3 | $344K | Buy |
10,371
+1,682
| +19% | +$55.8K | 0.11% | 147 |
|
|
2023
Q2 | $319K | Buy |
8,689
+3,169
| +57% | +$116K | 0.1% | 150 |
|
|
2023
Q1 | $225K | Sell |
5,520
-14,608
| -73% | -$596K | 0.08% | 161 |
|
|
2022
Q4 | $1.03M | Buy |
20,128
+14,970
| +290% | +$767K | 0.4% | 75 |
|
|
2022
Q3 | $226K | Buy |
5,158
+81
| +2% | +$3.55K | 0.1% | 143 |
|
|
2022
Q2 | $266K | Sell |
5,077
-140
| -3% | -$7.34K | 0.12% | 135 |
|
|
2022
Q1 | $270K | Sell |
5,217
-3,182
| -38% | -$165K | 0.07% | 171 |
|
|
2021
Q4 | $496K | Buy |
8,399
+797
| +10% | +$47.1K | 0.13% | 115 |
|
|
2021
Q3 | $327K | Sell |
7,602
-3,850
| -34% | -$166K | 0.09% | 158 |
|
|
2021
Q2 | $448K | Buy |
11,452
+2,913
| +34% | +$114K | 0.1% | 154 |
|
|
2021
Q1 | $309K | Sell |
8,539
-4,142
| -33% | -$150K | 0.08% | 170 |
|
|
2020
Q4 | $467K | Buy |
12,681
+4,971
| +64% | +$183K | 0.12% | 128 |
|
|
2020
Q3 | $283K | Buy |
7,710
+278
| +4% | +$10.2K | 0.08% | 171 |
|
|
2020
Q2 | $243K | Buy |
+7,432
| New | +$243K | 0.08% | 158 |
|
|
2019
Q3 | – | Sell |
-4,202
| Closed | -$182K | – | 348 |
|
|
2019
Q2 | $182K | Buy |
+4,202
| New | +$182K | 0.07% | 145 |
|